- Business Insider•yesterday
Danish pharmaceutical giant Novo Nordisk is being accused of engaging in a "white coat marketing...
Novo Nordisk A/S has agreed to settle a U.S. probe of its marketing of diabetes drugs that allegedly included disguising salespeople as medical educators and paying kickbacks to persuade doctors to prescribe ...
- GlobeNewswire•2 days ago
Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 28 April 2017
Bagsværd, Denmark, 28 April 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers` Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights ...
NOVO-B.CO : Summary for Novo Nordisk B A/S - Yahoo Finance
Novo Nordisk A/S (NOVO-B.CO)
Copenhagen - Copenhagen Real Time Price. Currency in DKK
Add to watchlist
|Day's Range||263.30 - 266.50|
|52 Week Range||218.20 - 384.80|
|PE Ratio (TTM)||17.76|
|Dividend & Yield||1.12 (3.07%)|
|1y Target Est||N/A|